RXMD is SOLID. It's PROFITABLE GROWING,
Post# of 98042
It's PROFITABLE
GROWING,
HAS LOWERED THE O/S FROM 352M LAST YEAR TO 345M THIS YEAR
$18M in SALES IN '16 WITH $22M TARGET FOR '17
CEO IN INVESTORS CONFERENCE CALL TODAY SAID NO DILUTION FOR THE NEAR FUTURE.
COMPANY CASH ON HAND IS $800K+
SHARE PRICE JUST BOUNCED HARD OFF 52 WEEK LOWS
This IS A BUY AND HOLD LONG.